107 related articles for article (PubMed ID: 11309304)
1. Gestational age and gender-specific in utero V(D)J recombinase-mediated deletions.
Yoshioka M; O'Neill JP; Vacek PM; Finette BA
Cancer Res; 2001 Apr; 61(8):3432-8. PubMed ID: 11309304
[TBL] [Abstract][Full Text] [Related]
2. V(D)J recombinase-mediated HPRT mutations in peripheral blood lymphocytes of normal children.
Finette BA; Poseno T; Albertini RJ
Cancer Res; 1996 Mar; 56(6):1405-12. PubMed ID: 8640832
[TBL] [Abstract][Full Text] [Related]
3. V(D)J recombinase-like activity mediates hprt gene deletion in human fetal T-lymphocytes.
Fuscoe JC; Zimmerman LJ; Lippert MJ; Nicklas JA; O'Neill JP; Albertini RJ
Cancer Res; 1991 Nov; 51(21):6001-5. PubMed ID: 1933863
[TBL] [Abstract][Full Text] [Related]
4. Gene mutations with characteristic deletions in cord blood T lymphocytes associated with passive maternal exposure to tobacco smoke.
Finette BA; O'Neill JP; Vacek PM; Albertini RJ
Nat Med; 1998 Oct; 4(10):1144-51. PubMed ID: 9771747
[TBL] [Abstract][Full Text] [Related]
5. V(D)J recombinase mediated inter-chromosomal HPRT alterations at cryptic recombination signal sequences in peripheral human T cells.
Messier TL; O'Neill JP; Finette BA
Hum Mutat; 2006 Aug; 27(8):829. PubMed ID: 16835902
[TBL] [Abstract][Full Text] [Related]
6. Analysis of mutagenic V(D)J recombinase mediated mutations at the HPRT locus as an in vivo model for studying rearrangements with leukemogenic potential in children.
Finette BA
DNA Repair (Amst); 2006 Sep; 5(9-10):1049-64. PubMed ID: 16807138
[TBL] [Abstract][Full Text] [Related]
7. HPRT gene alterations in umbilical cord blood T-lymphocytes in newborns of mothers exposed to tobacco smoke during pregnancy.
Keohavong P; Xi L; Day RD; Zhang L; Grant SG; Day BW; Ness RB; Bigbee WL
Mutat Res; 2005 May; 572(1-2):156-66. PubMed ID: 15790499
[TBL] [Abstract][Full Text] [Related]
8. Kinds and locations of mutations induced in the hypoxanthine-guanine phosphoribosyltransferase gene of human T-lymphocytes by 1-nitrosopyrene, including those caused by V(D)J recombinase.
McGregor WG; Maher VM; McCormick JJ
Cancer Res; 1994 Aug; 54(15):4207-13. PubMed ID: 8033153
[TBL] [Abstract][Full Text] [Related]
9. Impact of maternal lifestyle factors on newborn HPRT mutant frequencies and molecular spectrum--initial results from the Prenatal Exposures and Preeclampsia Prevention (PEPP) Study.
Bigbee WL; Day RD; Grant SG; Keohavong P; Xi L; Zhang L; Ness RB
Mutat Res; 1999 Dec; 431(2):279-89. PubMed ID: 10635994
[TBL] [Abstract][Full Text] [Related]
10. Molecular analysis of mutations at the HPRT and TK loci of human lymphoblastoid cells after combined treatments with 3'-azido-3'-deoxythymidine and 2',3'-dideoxyinosinedagger.
Meng Q; Su T; O'Neill JP; Walker VE
Environ Mol Mutagen; 2002; 39(4):282-95. PubMed ID: 12112380
[TBL] [Abstract][Full Text] [Related]
11. V(D)J recombinase-mediated deletion of the hprt gene in T-lymphocytes from adult humans.
Fuscoe JC; Zimmerman LJ; Harrington-Brock K; Burnette L; Moore MM; Nicklas JA; O'Neill JP; Albertini RJ
Mutat Res; 1992 Sep; 283(1):13-20. PubMed ID: 1380658
[TBL] [Abstract][Full Text] [Related]
12. Quantification of illegitimate V(D)J recombinase-mediated mutations in lymphocytes of newborns and adults.
Scheerer JB; Xi L; Knapp GW; Setzer RW; Bigbee WL; Fuscoe JC
Mutat Res; 1999 Dec; 431(2):291-303. PubMed ID: 10635995
[TBL] [Abstract][Full Text] [Related]
13. A comparison of somatic mutational spectra in healthy study populations from Russia, Sweden and USA.
Noori P; Hou S; Jones IM; Thomas CB; Lambert B
Carcinogenesis; 2005 Jun; 26(6):1138-51. PubMed ID: 15731167
[TBL] [Abstract][Full Text] [Related]
14. Deletion and insertion in vivo somatic mutations in the hypoxanthine phosphoribosyltransferase (hprt) gene of human T-lymphocytes.
Burkhart-Schultz KJ; Jones IM
Environ Mol Mutagen; 1997; 30(4):371-84. PubMed ID: 9435878
[TBL] [Abstract][Full Text] [Related]
15. Comparative analysis of HPRT mutant frequency in children with cancer.
Rice SC; Vacek PM; Homans AH; Kendall H; Rivers J; Messier T; Finette BA
Environ Mol Mutagen; 2003; 42(1):44-9. PubMed ID: 12874812
[TBL] [Abstract][Full Text] [Related]
16. A human lymphoid leukemia cell line with a V(D)J recombinase-mediated deletion of hprt.
Chen CL; Woo MH; Neale GA; Goorha RM; Fuscoe JC; Behm FG; Mathew S; Relling MV
Mutat Res; 1998 Jul; 403(1-2):113-25. PubMed ID: 9726012
[TBL] [Abstract][Full Text] [Related]
17. Characterization of Hprt mutations in cDNA and genomic DNA of T-cell mutants from control and 1,3-butadiene-exposed male B6C3F1 mice and F344 rats.
Meng Q; Walker DM; Scott BR; Seilkop SK; Aden JK; Walker VE
Environ Mol Mutagen; 2004; 43(2):75-92. PubMed ID: 14991748
[TBL] [Abstract][Full Text] [Related]
18. Gender-specific frequency of background somatic mutations at the hypoxanthine phosphoribosyltransferase locus in cord blood T lymphocytes from preterm newborns.
Yoshioka M; Vacek PM; Poseno T; Silver R; Finette BA
Proc Natl Acad Sci U S A; 1999 Jan; 96(2):586-91. PubMed ID: 9892677
[TBL] [Abstract][Full Text] [Related]
19. Molecular spectra of HPRT deletion mutations in circulating T-lymphocytes in Fanconi anemia patients.
Laquerbe A; Sala-Trepat M; Vives C; Escarceller M; Papadopoulo D
Mutat Res; 1999 Dec; 431(2):341-50. PubMed ID: 10635999
[TBL] [Abstract][Full Text] [Related]
20. Mutational spectral analysis at the HPRT locus in healthy children.
Finette BA; Kendall H; Vacek PM
Mutat Res; 2002 Aug; 505(1-2):27-41. PubMed ID: 12175903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]